BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 88 filers reported holding BRIDGEBIO PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,919,000 | -63.3% | 294,879 | +3.1% | 0.31% | -68.2% |
| Q3 2021 | $13,411,000 | -51.3% | 286,132 | -36.7% | 0.98% | -43.3% |
| Q2 2021 | $27,553,000 | -8.6% | 451,982 | -7.7% | 1.73% | -17.8% |
| Q1 2021 | $30,161,000 | +3.0% | 489,623 | +18.9% | 2.10% | -7.1% |
| Q4 2020 | $29,281,000 | +166.4% | 411,771 | +40.5% | 2.26% | +90.4% |
| Q3 2020 | $10,993,000 | +531.8% | 292,982 | +449.1% | 1.19% | +236.5% |
| Q2 2020 | $1,740,000 | -0.7% | 53,356 | -11.7% | 0.35% | +3.5% |
| Q1 2020 | $1,752,000 | +152.4% | 60,424 | +205.0% | 0.34% | +380.3% |
| Q4 2019 | $694,000 | +216.9% | 19,809 | +94.5% | 0.07% | +294.4% |
| Q3 2019 | $219,000 | – | 10,185 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
| Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
| Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
| Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
| M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
| VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
| BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
| Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
| SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |